Key Facts

• The expert had lost 40 pounds and was asked if she used a weight-loss medication called Ozempic, but she was actually using Tirzepatide.
• Tirzepatide is a medication categorized as a glucagon-like peptide-1 (GLP-1).
• The article mentions that there's a societal belief that body confidence and using weight-loss drugs cannot coexist.
• The expert initially resisted GLP-1s due to negative stereotypes but later reconsidered due to personal health issues.
• She faced challenges with hormone shifts, weight gain, and physical discomfort.
• The article explains intuitive eating and how it did not work for her due to stress and past dieting habits.
• Serena Williams faced public criticism when she disclosed using GLP-1s in collaboration with a company called Ro.
• Discussion around weight-loss medication brings up themes of diet culture and body positivity rules.